Article Versions Notes

Mader N, Groener D, Tselis N, Banek S, Nagarajah J, Grünwald F, Sabet A. Outcome of ¹⁷⁷Lu-PSMA-617 Radioligand Therapy in Chemo-Refractory Patients with Metastatic Castration-Resistant Early-Onset Prostate Cancer. Cancers. 2021; 13(16):4193. https://doi.org/10.3390/cancers13164193

Mader, Nicolai, Daniel Groener, Nikolaos Tselis, Séverine Banek, James Nagarajah, Frank Grünwald, and Amir Sabet. 2021. "Outcome of ¹⁷⁷Lu-PSMA-617 Radioligand Therapy in Chemo-Refractory Patients with Metastatic Castration-Resistant Early-Onset Prostate Cancer" Cancers 13, no. 16: 4193. https://doi.org/10.3390/cancers13164193

Mader, N., Groener, D., Tselis, N., Banek, S., Nagarajah, J., Grünwald, F., & Sabet, A. (2021). Outcome of ¹⁷⁷Lu-PSMA-617 Radioligand Therapy in Chemo-Refractory Patients with Metastatic Castration-Resistant Early-Onset Prostate Cancer. Cancers, 13(16), 4193. https://doi.org/10.3390/cancers13164193